DCAMKL-1: a new horizon for pancreatic progenitor identification
Author(s) -
Simon M. Mwangi,
Shanthi Srinivasan
Publication year - 2010
Publication title -
ajp gastrointestinal and liver physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.644
H-Index - 169
eISSN - 1522-1547
pISSN - 0193-1857
DOI - 10.1152/ajpgi.00259.2010
Subject(s) - progenitor cell , pancreas , stem cell , biology , embryonic stem cell , transplantation , cancer research , pancreatic cancer , progenitor , microbiology and biotechnology , pancreatic islets , insulin , immunology , medicine , islet , endocrinology , cancer , genetics , gene
type 1 diabetes results from the autoimmune destruction of insulin-producing pancreatic β-cells. Although islet transplantation has shown great potential in the treatment of hyperglycemia in type 1 diabetes patients, availability of donor islets remains a major obstacle ([4][1]). Cell replacement
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom